Clinical Trial Update: Study to Investigate the Pharmacokinetic Comparability of Dosing Triferic AVNU IV by Continuous Infusion and IV Bolus. [Phase 1, Phase 2]

View source ↗

Summary

A pharmacokinetic comparability study of Triferic AVNU IV administered by continuous infusion versus IV bolus in End Stage Renal Disease has completed (Phase 1/…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Triferic AVNU (ferric pyrophosphate citrate)

Snippet

Sponsor: Rockwell Medical Technologies, Inc. | Conditions: End Stage Renal Disease | Phase 1, Phase 2 | Status: COMPLETED